Valuation: Orthofix Medical Inc.

Market Cap 408M 349M 327M 299M 561M 39.01B 569M 3.86B 1.51B 19.6B 1.53B 1.5B 64.82B P/E 2026 *
-10.5x
P/E 2027 * -11.8x
Enterprise Value 408M 349M 327M 299M 561M 39.01B 569M 3.86B 1.51B 19.6B 1.53B 1.5B 64.82B EV / Sales 2026 *
0.48x
EV / Sales 2027 * 0.47x
Free-Float
97.82%
Yield 2026 *
-
Yield 2027 * -
1 week-3.19%
Current month-15.17%
1 month-9.17%
3 months-6.88%
6 months-27.83%
Current year-33.97%
1 week 9.78
Extreme 9.78
10.74
1 month 9.78
Extreme 9.78
12.58
Current year 8.85
Extreme 8.85
16.42
1 year 8.85
Extreme 8.85
16.99
3 years 8.85
Extreme 8.85
21.6
5 years 8.85
Extreme 8.85
43.3
10 years 8.85
Extreme 8.85
74.44
Manager TitleAgeSince
Chief Executive Officer 54 07/01/2024
Director of Finance/CFO 55 14/01/2024
Compliance Officer - 31/01/2015
Director TitleAgeSince
Director/Board Member 66 15/03/2016
Director/Board Member 54 07/06/2020
Director/Board Member 64 04/01/2023
Date Insider Type Main position Quantity % Market Cap.
18/08/26 Sell

Executive/Senior Manager

-1,295 0.0032%
17/08/26
Juniper Investment Co. LLC
SellCompany 20,000 0.0495%
10/06/26 Free

Director

14,965 0.0370%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-3.19%-31.20%-45.77% 408M
+2.19%+4.84%-12.03%+10.93% 202B
+1.14%+2.28%+0.69%+11.50% 119B
+1.06%+1.34%+8.69%+78.71% 60.69B
-1.37%-6.57%+30.31%+55.01% 52.38B
+2.33%+4.69%-3.84%-30.36% 52.3B
+2.35%+2.89%+12.25%-13.68% 34.85B
+5.16%-4.14% - - 30.06B
-0.20%+1.05%+42.46%-10.20% 24.85B
-0.29%-3.87%-6.19%+25.59% 23.84B
Average +1.24%-0.07%+4.57%+9.08% 60.07B
Weighted average by Cap. +1.53%+1.90%+1.56%+16.67%

Financials

2026 *2027 *
Net sales 851M 729M 682M 624M 1.17B 81.42B 1.19B 8.06B 3.14B 40.9B 3.2B 3.13B 135B 872M 747M 699M 640M 1.2B 83.42B 1.22B 8.26B 3.22B 41.91B 3.27B 3.2B 139B
Net income -36.35M -31.14M -29.14M -26.67M -50.05M -3.48B -50.71M -344M -134M -1.75B -136M -134M -5.78B -40.48M -34.67M -32.44M -29.7M -55.73M -3.87B -56.47M -383M -149M -1.95B -152M -149M -6.43B
Net Debt - -
Logo Orthofix Medical Inc.
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Employees
1,605
Date Price Change Volume
21/08/26 US$10.01 0.00% 415,384
20/08/26 US$10.01 -4.48% 225,284
19/08/26 US$10.48 +2.54% 204,006
18/08/26 US$10.22 +1.89% 234,064
17/08/26 US$10.03 -3.00% 233,386
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
10.01USD
Average target price
13.00USD
Spread / Average Target
+29.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OFIX Stock